IL38991A - Optically active 1,3-dihydro-5-phenyl-3-substituted 1,4-benzodiazepin-2-ones and their preparation - Google Patents
Optically active 1,3-dihydro-5-phenyl-3-substituted 1,4-benzodiazepin-2-ones and their preparationInfo
- Publication number
- IL38991A IL38991A IL38991A IL3899172A IL38991A IL 38991 A IL38991 A IL 38991A IL 38991 A IL38991 A IL 38991A IL 3899172 A IL3899172 A IL 3899172A IL 38991 A IL38991 A IL 38991A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- benzodiazepin
- dihydro
- ones
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH386871A CH554349A (de) | 1971-03-17 | 1971-03-17 | Verfahren zur herstellung von optisch aktiven 1,3-dihydro-2h-1,4-benzodiazepin-2-onen. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL38991A0 IL38991A0 (en) | 1972-05-30 |
| IL38991A true IL38991A (en) | 1976-09-30 |
Family
ID=4265209
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL38991A IL38991A (en) | 1971-03-17 | 1972-03-16 | Optically active 1,3-dihydro-5-phenyl-3-substituted 1,4-benzodiazepin-2-ones and their preparation |
| IL47123A IL47123A (en) | 1971-03-17 | 1972-03-16 | Optically active 2-acylamino benzophenones and their preparation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL47123A IL47123A (en) | 1971-03-17 | 1972-03-16 | Optically active 2-acylamino benzophenones and their preparation |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT327909B (sv) |
| BE (1) | BE780892A (sv) |
| CA (1) | CA992079A (sv) |
| CH (1) | CH554349A (sv) |
| DE (1) | DE2212526A1 (sv) |
| ES (1) | ES400851A1 (sv) |
| FR (1) | FR2130342B1 (sv) |
| GB (2) | GB1391082A (sv) |
| HU (1) | HU165496B (sv) |
| IL (2) | IL38991A (sv) |
| NL (1) | NL7203536A (sv) |
| NO (1) | NO137896C (sv) |
| SE (1) | SE399887B (sv) |
| SU (1) | SU453842A3 (sv) |
| YU (1) | YU34882B (sv) |
| ZA (1) | ZA721845B (sv) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH602672A5 (sv) * | 1974-06-28 | 1978-07-31 | Hoffmann La Roche | |
| CH603655A5 (sv) * | 1974-10-21 | 1978-08-31 | Hoffmann La Roche | |
| AU6420700A (en) * | 1999-08-05 | 2001-03-05 | Prescient Neuropharma Inc. | Novel 1,4-benzodiazepine compounds and derivatives thereof |
-
1971
- 1971-03-17 CH CH386871A patent/CH554349A/xx not_active IP Right Cessation
-
1972
- 1972-03-14 AT AT214972A patent/AT327909B/de not_active IP Right Cessation
- 1972-03-15 DE DE19722212526 patent/DE2212526A1/de active Pending
- 1972-03-16 FR FR7209250A patent/FR2130342B1/fr not_active Expired
- 1972-03-16 IL IL38991A patent/IL38991A/en unknown
- 1972-03-16 IL IL47123A patent/IL47123A/en unknown
- 1972-03-16 ES ES72400851A patent/ES400851A1/es not_active Expired
- 1972-03-16 NO NO853/72A patent/NO137896C/no unknown
- 1972-03-16 YU YU697/72A patent/YU34882B/xx unknown
- 1972-03-16 NL NL7203536A patent/NL7203536A/xx unknown
- 1972-03-16 CA CA137,294A patent/CA992079A/en not_active Expired
- 1972-03-17 GB GB4955674A patent/GB1391082A/en not_active Expired
- 1972-03-17 SU SU1761120A patent/SU453842A3/ru active
- 1972-03-17 ZA ZA721845A patent/ZA721845B/xx unknown
- 1972-03-17 GB GB1256772A patent/GB1391081A/en not_active Expired
- 1972-03-17 BE BE780892A patent/BE780892A/xx unknown
- 1972-03-17 HU HUCA323A patent/HU165496B/hu unknown
- 1972-03-17 SE SE7203457A patent/SE399887B/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA721845B (en) | 1972-12-27 |
| GB1391081A (en) | 1975-04-16 |
| NO137896B (no) | 1978-02-06 |
| FR2130342A1 (sv) | 1972-11-03 |
| SE399887B (sv) | 1978-03-06 |
| BE780892A (fr) | 1972-07-17 |
| CH554349A (de) | 1974-09-30 |
| AT327909B (de) | 1976-02-25 |
| YU69772A (en) | 1979-10-31 |
| ATA214972A (de) | 1975-05-15 |
| NO137896C (no) | 1978-05-16 |
| SU453842A3 (sv) | 1974-12-15 |
| HU165496B (sv) | 1974-09-28 |
| NL7203536A (sv) | 1972-09-19 |
| CA992079A (en) | 1976-06-29 |
| FR2130342B1 (sv) | 1977-01-14 |
| IL47123A (en) | 1976-09-30 |
| ES400851A1 (es) | 1975-01-16 |
| GB1391082A (en) | 1975-04-16 |
| YU34882B (en) | 1980-04-30 |
| IL38991A0 (en) | 1972-05-30 |
| DE2212526A1 (de) | 1972-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU465055B2 (en) | Benzofurance derivatives, process for their preparatin and their use as optical brighteners | |
| AU464663B2 (en) | Improvements in or relating to 1,4-dihydro pyridinedicarboxylic acid esters | |
| AU466696B2 (en) | For improvements in or relating tothe production of flame-resistant laminates | |
| CA982128A (en) | Monostyryl-naphthalene derivatives, process for their preparation and their use as optical brighteners | |
| CA967164A (en) | Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol | |
| IE39836L (en) | Substituted amino-benzoic acid derivatives | |
| AU468312B2 (en) | Improvements in or relating to rubber articles | |
| AU3926472A (en) | Improvements in or relating to seats | |
| AU472050B2 (en) | Tank clarification plant | |
| AU463610B2 (en) | Improvements in or relating to optical deflection systems | |
| IL38991A (en) | Optically active 1,3-dihydro-5-phenyl-3-substituted 1,4-benzodiazepin-2-ones and their preparation | |
| AU7641974A (en) | Improvements in or relating to the manufacture of hollow elastomeric articles | |
| AU450660B2 (en) | Improvements in or relating to marine fenders | |
| AU4782672A (en) | Improvements in or relating to mooring system | |
| AU471554B2 (en) | Improvements in or relating to code-controlled typewriters | |
| CA924640A (en) | Orgotein purification process | |
| IE34011B1 (en) | New penicillin esters | |
| AU463293B2 (en) | Calandria vessels | |
| AU456474B2 (en) | Improvements in or relating to nozzles | |
| AU448611B2 (en) | Improvements in or relating to storage systems | |
| AU487874B2 (en) | Improvements in or relating to hydromechanical transmissions | |
| AU4725872A (en) | Improvements in or relating to carriers for containers | |
| CA875039A (en) | Ternary copolyamides, fibers and process for the preparation thereof | |
| GB1337433A (en) | Mono-mooring structure | |
| AU456290B2 (en) | Improvements in or relating to telecommunication assemblies |